Cargando…

Strategies for power calculations in predictive biomarker studies in survival data

PURPOSE: Biomarkers and genomic signatures represent potentially predictive tools for precision medicine. Validation of predictive biomarkers in prospective or retrospective studies requires statistical justification of power and sample size. However, the design of these studies is complex and the s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Dung-Tsa, Huang, Po-Yu, Lin, Hui-Yi, Haura, Eric B., Antonia, Scott J., Cress, W. Douglas, Gray, Jhanelle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348326/ https://www.ncbi.nlm.nih.gov/pubmed/27661007 http://dx.doi.org/10.18632/oncotarget.12124

Ejemplares similares

A Bayesian pick-the-winner design in a randomized phase II clinical trial
por: Chen, Dung-Tsa, et al.
Publicado: (2017)

Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial
por: Chen, Dung-Tsa, et al.
Publicado: (2019)

Early2 factor (E2F) deregulation is a prognostic and predictive biomarker in lung adenocarcinoma
por: Chen, Lu, et al.
Publicado: (2016)

Impact of COVID-19 Pandemic on Frontline Pembrolizumab-Based Treatment for Advanced Lung Cancer
por: Tanvetyanon, Tawee, et al.
Publicado: (2023)

Early Adverse Event Derived Biomarkers in Predicting Clinical Outcomes in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy
por: Chen, Dung-Tsa, et al.
Publicado: (2023)

Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma
por: Schabath, Matthew B., et al.
Publicado: (2015)

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer
por: Chiappori, Alberto A., et al.
Publicado: (2018)

Utilization of target lesion heterogeneity for treatment efficacy assessment in late stage lung cancer
por: Chen, Dung-Tsa, et al.
Publicado: (2021)

Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance
por: Creelan, Ben C., et al.
Publicado: (2019)

Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
por: Gordian, Edna, et al.
Publicado: (2019)

Correction: Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer
por: Gordian, Edna, et al.
Publicado: (2021)

Translating Hispanic Genomic Factors in Lung Cancer Into Clinical Practice: EGFR Testing for Improved Outcomes
por: Hudson, Janella, et al.
Publicado: (2016)

Histone Deacetylase Inhibitors Downregulate Checkpoint Kinase 1 Expression to Induce Cell Death in Non-Small Cell Lung Cancer Cells
por: Brazelle, William, et al.
Publicado: (2010)

Strategies for formula constant optimisation for intraocular lens power calculation
por: Langenbucher, Achim, et al.
Publicado: (2022)

Biomarkers of therapeutic response with immune checkpoint inhibitors
por: Bindal, Poorva, et al.
Publicado: (2021)

Calculation of Toric Intraocular Lens Power with the Barrett Calculator and Data from Three Keratometers
por: Dong, Jing, et al.
Publicado: (2021)

Reconsideration of sample size and power calculation for overall survival in cancer clinical trials
por: Jung, Inkyung, et al.
Publicado: (2018)

SurvivalGWAS_Power: a user friendly tool for power calculations in pharmacogenetic studies with “time to event” outcomes
por: Syed, Hamzah, et al.
Publicado: (2016)

Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors
por: Creelan, Ben C, et al.
Publicado: (2017)

Handbook of electric power calculations /
Publicado: (2001)

Hypothesis Testing and Power Calculations for Taxonomic-Based Human Microbiome Data
por: La Rosa, Patricio S., et al.
Publicado: (2012)

Clinical associations of mucin 1 in human lung cancer and precancerous lesions
por: Saltos, Andreas, et al.
Publicado: (2018)

Power calculations for detecting differences in efficacy of fecal microbiota donors
por: Olesen, Scott W.
Publicado: (2020)

Power generation calculations reference guide
Publicado: (1987)

Comparison of two optical biometers in intraocular lens power calculation
por: Hui, Sheng, et al.
Publicado: (2014)

A phase I/randomized phase II study of GM.CD40L vaccine in combination with CCL21 in patients with advanced lung adenocarcinoma
por: Gray, Jhanelle E., et al.
Publicado: (2018)

Predictive Value of Intraocular Lens Power Calculation Formulae in Children
por: Shuaib, Asmaa M, et al.
Publicado: (2021)

Trim28 Contributes to EMT via Regulation of E-Cadherin and N-Cadherin in Lung Cancer Cell Lines
por: Chen, Lu, et al.
Publicado: (2014)

Calculation of power dissipation in the TPC resistor chains
por: Garabatos, C, et al.
Publicado: (2001)

TESLA RF Power Coupler Thermal Calculations
por: Kostin, D, et al.
Publicado: (2004)

Intraocular lens power calculation for the equine eye
por: Meister, Ulrike, et al.
Publicado: (2018)

Power calculator for instrumental variable analysis in pharmacoepidemiology
por: Walker, Venexia M, et al.
Publicado: (2017)

Accuracy of IOL power calculations in the very elderly
por: Sella, Ruti, et al.
Publicado: (2020)

Comparison of Newer IOL Power Calculation Methods for Eyes With Previous Radial Keratotomy
por: Ma, Jack X., et al.
Publicado: (2016)

Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
por: Dhawan, Andrew, et al.
Publicado: (2017)

Development and application of equilibrium optimizer for optimal power flow calculation of power system
por: Houssein, Essam H., et al.
Publicado: (2022)

Intraocular lens power calculations in eyes with previous corneal refractive surgery: Challenges, approaches, and outcomes
por: Wang, Li, et al.
Publicado: (2021)

Prediction error and accuracy of intraocular lens power calculation in pediatric patient comparing SRK II and Pediatric IOL Calculator
por: Jasman, Azlyn-Azwa, et al.
Publicado: (2010)

Power Calculations Using Exact Data Simulation: A Useful Tool for Genetic Study Designs
por: van der Sluis, Sophie, et al.
Publicado: (2007)

Polygenic power calculator: Statistical power and polygenic prediction accuracy of genome-wide association studies of complex traits
por: Wu, Tian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4f3pr8vbs4asuikub5jctics58